Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
<p>Abstract</p> <p>Background</p> <p>T-cell based immunotherapy for lung cancer (LC) could be a promising and novel therapeutic approach. Six-transmembrane epithelial antigen of the prostate (STEAP) and the polycomb group protein enhancer of zeste homolog 2 (EZH2) are h...
Main Authors: | Kimura Shoji, Sato Keisuke, Aoki Naoko, Matsuda Yoshiya, Kumai Takumi, Hayashi Satoshi, Kitada Masahiro, Tateno Masatoshi, Celis Esteban, Kobayashi Hiroya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/191 |
Similar Items
-
Enhancer of zeste homolog 2 regulates cell differentiation and proliferation in neuroblastoma
by: Amallia N. Setyawati, et al.
Published: (2014-12-01) -
Impact of Enhancer of Zeste Homolog 2 on T Helper Cell-Mediated Allergic Rhinitis
by: Tsung-Yun Hou, et al.
Published: (2017-07-01) -
Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation.
by: Salman A Aljubran, et al.
Published: (2012-01-01) -
Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
by: Yuanyuan Kang, et al.
Published: (2021-07-01) -
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
by: Qi Zhang, et al.
Published: (2017-07-01)